LONG-TERM EXPERIENCE WITH PERGOLIDE THERAPY OF ADVANCED PARKINSONISM

被引：30
作者：
KURLAN, R
MILLER, C
LEVY, R
MACIK, B
HAMILL, R
SHOULSON, I
机构：
来源：
NEUROLOGY | 1985年 / 35卷 / 05期
关键词：
D O I：
10.1212/WNL.35.5.738
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：738 / 742
页数：5
相关论文
共 31 条
[11]   THE PHARMACOLOGICAL EVALUATION OF PERGOLIDE MESYLATE AS A POTENTIAL ANTI-PARKINSON AGENT [J].
KOLLER, WC ;
WEINER, WJ ;
DIAMOND, BI ;
NAUSIEDA, PA ;
KLAWANS, HL .
NEUROPHARMACOLOGY, 1980, 19 (09) :831-837
[12]   UP AND DOWN REGULATION - CLINICAL-SIGNIFICANCE OF NERVOUS-SYSTEM RECEPTOR-DRUG INTERACTIONS [J].
KURLAN, R ;
SHOULSON, I .
CLINICAL NEUROPHARMACOLOGY, 1982, 5 (04) :345-350
[13]   PERGOLIDE IN LATE-STAGE PARKINSON DISEASE [J].
LANG, AE ;
QUINN, N ;
BRINCAT, S ;
MARSDEN, CD ;
PARKES, JD .
ANNALS OF NEUROLOGY, 1982, 12 (03) :243-247
[14]   CARDIAC EFFECTS OF PERGOLIDE [J].
LEIBOWITZ, M ;
LIEBERMAN, A ;
GOLDSTEIN, M ;
NEOPHYTIDES, A ;
KUPERSMITH, M ;
GOPINATHAN, G ;
MEHL, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (06) :718-723
[15]   PHARMACOLOGIC EFFECTS IN MAN OF A POTENT, LONG-ACTING DOPAMINE RECEPTOR AGONIST [J].
LEMBERGER, L ;
CRABTREE, RE .
SCIENCE, 1979, 205 (4411) :1151-1153
[16]   TREATMENT OF ADVANCED PARKINSON DISEASE WITH PERGOLIDE [J].
LIEBERMAN, A ;
GOLDSTEIN, M ;
LEIBOWITZ, M ;
NEOPHYTIDES, A ;
KUPERSMITH, M ;
PACT, V ;
KLEINBERG, D .
NEUROLOGY, 1981, 31 (06) :675-682
[17]   THE USE OF PERGOLIDE, A POTENT DOPAMINE AGONIST, IN PARKINSONS-DISEASE [J].
LIEBERMAN, AN ;
GOLDSTEIN, M ;
NEOPHYTIDES, A ;
LEIBOWITZ, M ;
GOPINATHAN, G ;
WALKER, R ;
PACT, V .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :70-75
[18]   FURTHER-STUDIES WITH PERGOLIDE IN PARKINSON DISEASE [J].
LIEBERMAN, AN ;
GOLDSTEIN, M ;
GOPINATHAN, G ;
LEIBOWITZ, M ;
NEOPHYTIDES, A ;
WALKER, R ;
HIESIGER, E ;
NELSON, J .
NEUROLOGY, 1982, 32 (10) :1181-1184
[19]  
LIEBERMAN AN, 1984, NEUROLOGY, V34, P223
[20]  
LIEBERMAN AN, 1982, MOVEMENT DISORD, P146
1234